Asston Pharmaceuticals Board to Consider H1 FY27 Results on 12th Nov'26
Asston Pharmaceuticals Ltd 路 Intimation 路 12 Nov 2026, 5:30 am
Asston Pharmaceuticals Board to Consider H1 FY27 Results on 12th Nov'26 Asston Pharmaceuticals Limited has scheduled a meeting of its Board of Directors on 12th Nov'26 to consider and approve the unaudited financial statements along with the limited review report for the half-year ended 30th Sep'26, alongside other incidental matters.
Original exchange filing (PDF)
More announcements from Asston Pharmaceuticals Ltd
- Unaudited Financial Results for the Half Year ended 30 September, 2026 with Limited Review Report. 路 12 Nov 2026
- Outcome of the Board Meeting 路 12 Nov 2026
- Change in registered office address 路 13 Oct 2026
- Outcome of the Board held on 13th October, 2026. 路 13 Oct 2026
- Asston Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/10/2026 ,inter alia, to consider and approve matters as attached 路 06 Oct 2026
- Change in Management 路 01 Oct 2026
- Appointment of Statutory Auditor of the Company 路 01 Oct 2026
- Scrutinizer Report 路 01 Oct 2026
